WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
At the end of February, the net asset value per share of CN SCI-TECH IND (00339) was approximately 0.0258 Hong Kong dollars.
SIM TECH's revenue from its main business in February 2020 was HKD 33.7 million, an increase of 25.2% year-on-year.
POU SHENG INT'L (03813) February total operating income net approximately 1.9515 billion yuan, representing a year-on-year increase of 81.5%.
At the end of February, the net asset value per share of CN SCI-TECH IND (00339) was approximately 0.0258 Hong Kong dollars.
SIM TECH's revenue from its main business in February 2020 was HKD 33.7 million, an increase of 25.2% year-on-year.
POU SHENG INT'L (03813) February total operating income net approximately 1.9515 billion yuan, representing a year-on-year increase of 81.5%.
RECOMMEND
Local Policies Experiment With “Lobster” AI Agents Accelerate Into The Agent Era But Security Risks Remain
10/03/2026
Hong Kong And Macau Join Billion‑Level Guidance Fund Initiative Hong Kong Sets Return‑Investment KPI Macau Targets MOP 20 Billion
10/03/2026
Southbound Capital Sells Heavily Yet Hang Seng Tech Advances How Do Fund Managers Interpret It
10/03/2026
